We also report here that Niaspan is effective in reducing the number of tomacula in the Pmp22+/− mouse, a model of the HNPP (hereditary neuropathy with liability to pressure palsies) neuropathy. This evidence concerns the gene PMP22 and hereditary neuropathy with liability to pressure palsies.